PathCision Medicine Chosen to Participate in MassBio's MassBioDrive Fall 2023 Cohort
PathCision Medicine is 1 of 5 chosen to participate in the Fall 2023 Cohort of MassBioDrive, MassBio's flagship accelerator!
In the next eight weeks, they will learn from industry mentors and expand their network in the Massachusetts biopharma ecosystem.
Learn more